Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancer.

Abstract

The alteration in paclitaxel pharmacokinetics when paclitaxel and R-verapamil are coadministered complicates the interpretation of response and toxicity data from clinical trials of this drug combination.